Clinical Efficacy of Empirical Therapy in Children with Vasovagal Syncope

被引:9
|
作者
Tao, Chunyan [1 ,2 ]
Cui, Yaxi [1 ]
Zhang, Chunyu [1 ]
Liu, Xueqin [1 ]
Zhang, Qingyou [1 ]
Liu, Ping [1 ]
Wang, Yuli [1 ]
Du, Junbao [1 ,3 ]
Jin, Hongfang [1 ]
机构
[1] Peking Univ First Hosp, Dept Pediat, Beijing 100034, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Genet & Endocrinol, Guangzhou 510623, Peoples R China
[3] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China
来源
CHILDREN-BASEL | 2022年 / 9卷 / 07期
关键词
children; efficacy; empiric therapy; vasovagal syncope; PEDIATRIC SYNCOPE; ORTHOSTATIC TOLERANCE; ADOLESCENTS; MANAGEMENT; RECURRENCE;
D O I
10.3390/children9071065
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
(1) Background: This case-control study was designed to assess the efficacy of empiric treatment for vasovagal syncope in children; (2) Methods: We retrospectively enrolled 181 children with vasovagal syncope from the Department of Pediatrics of Peking University First Hospital. The participants were categorized into four groups, based on the empiric treatment received: conventional treatment, including health education and orthostatic training; conventional treatment plus oral rehydration salts; conventional treatment plus metoprolol; conventional treatment plus midodrine hydrochloride. Patients were followed up to evaluate the syncopal or presyncopal recurrence. Kaplan-Meier curves were drawn to explore the syncopal or presyncopal recurrence in children, and the differences were compared among the groups using a log-rank test; (3) Results: Among the 181 children with vasovagal syncope, 11 were lost to follow-up. The median time of follow-up was 20 (8, 42) months. The Kaplan-Meier survival curve showed no significant difference in syncopal or presyncopal recurrence in children treated with different empiric options according to a log-rank test (chi(2) = 1.328, p = 0.723); (4) Conclusions: The efficacy of unselected empiric therapy of vasovagal syncope in children was limited, and the individualized therapies merit further studies.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope
    Zhang Qingyou
    Du Junbao
    Tang Chaoshu
    [J]. JOURNAL OF PEDIATRICS, 2006, 149 (06): : 777 - 780
  • [2] Clinical Efficacy of Catheter Ablation in the Treatment of Vasovagal Syncope
    Xu, Lingping
    Zhao, Yixin
    Duan, Yichao
    Wang, Rui
    Hou, Junlong
    Wang, Jing
    Chen, Bin
    Yang, Ye
    Xue, Xianjun
    Zhao, Yongyong
    Zhang, Bo
    Sun, Chaofeng
    Guo, Fengwei
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [3] Vasovagal syncope in children
    Teyssier, G.
    Patural, H.
    Barthelemy, J. -C.
    [J]. ARCHIVES DE PEDIATRIE, 2010, 17 (06): : 995 - 996
  • [4] EFFICACY OF PINDOLOL FOR TREATMENT OF VASOVAGAL SYNCOPE
    COHEN, MB
    SNOW, JS
    GRASSO, V
    LEHNERT, L
    GOLDNER, BG
    JADONATH, RL
    COHEN, TJ
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (04) : 786 - 790
  • [5] Efficacy of catheter ablation in ganglionated plexus for malignant vasovagal syncope children
    Li, Hongxia
    Shao, Wei
    Yu, Xia
    Gao, Lu
    Yuan, Yue
    [J]. CARDIOLOGY IN THE YOUNG, 2024,
  • [6] Predicting therapeutic efficacy of oral rehydration salts in children with vasovagal syncope
    Du, Xiaojuan
    Tao, Chunyan
    Li, Xueying
    Du, Junbao
    Liao, Ying
    Jin, Hongfang
    [J]. FRONTIERS IN PEDIATRICS, 2023, 11
  • [7] Acceleration Index Predicts Efficacy of Orthostatic Training on Vasovagal Syncope in Children
    Tao, Chunyan
    Li, Xueying
    Tang, Chaoshu
    Jin, Hongfang
    Du, Junbao
    [J]. JOURNAL OF PEDIATRICS, 2019, 207 : 54 - 58
  • [8] Management and therapy of vasovagal syncope: A review
    Aydin, Muhammet Ali
    Salukhe, Tushar V.
    Wilke, Iris
    Willems, Stephan
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2010, 2 (10): : 308 - 315
  • [9] Pharmacologic approaches to therapy for vasovagal syncope
    Calkins, H
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (8A): : 20Q - 25Q
  • [10] Components of clinical trials for vasovagal syncope
    Sheldon, R
    Rose, S
    [J]. EUROPACE, 2001, 3 (03): : 233 - 240